HDAC2 promoted hepatocellular carcinoma cell proliferation by increasing the expression of cell cycle-related proteins, such as cyclin D1, cyclin-dependent kinase 4 (CDK4), and phospho-Rb [52]. Here, CDK4 is linked to hepatocellular carcinoma.